Human Heart Transplantation Stress Granule Mediated Cellular Preservation

Overview

About this study

The purpose of this study is to improve heart transplantation and clinical outcomes for transplant patients. The study will enroll individuals who are scheduled for heart surgery where samples from their heart will be collected as part of the normal surgical procedure.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adults 18 years or older.
  • Individuals with various types of cardiomyopathy, including idiopathic dilated cardiomyopathy (familial cardiomyopathy), ischemic cardiomyopathy, hypertrophic cardiomyopathy, hypertensive cardiomyopathy, amyloid or other infiltrative cardiomyopathies.
  • Myocardium from any patient that enters the Heart Transplant Program at Mayo Clinic Florida irrespective of specific underlying pathophysiological mechanism.

Exclusion Criteria:

  • < 18 years of age.

Eligibility last updated 9/14/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Jay Schneider, M.D., Ph.D.

Open for enrollment

Contact information:

Jay Schneider M.D., Ph.D.

(904) 953-6351

Schneider.Jay1@mayo.edu

More information

Publications

Publications are currently not available